Phibro Animal Health (PAHC)
NASDAQ:PAHC
PAHC Stock Chart & Stats
$53.88
-$0.12(-0.58%)
At close: 4:00 PM EST
$53.88
-$0.12(-0.58%)
Day’s Range― - ―
52-Week Range$16.16 - $57.62
Previous CloseN/A
Volume17.41K
Average Volume (3M)277.01K
Market Cap
$2.19B
Enterprise Value$2.90B
Total Cash (Recent Filing)$74.51M
Total Debt (Recent Filing)$773.17M
Price to Earnings (P/E)13.8
Beta1.07
Next Earnings
May 13, 2026EPS Estimate
0.71Next Dividend Ex-DateN/A
Dividend Yield1.28%
Share Statistics
EPS (TTM)0.87
Shares Outstanding20,623,682
10 Day Avg. Volume355,551
30 Day Avg. Volume277,008
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)3.62
Price to Sales (P/S)0.80
P/FCF Ratio24.73
Enterprise Value/Market Cap1.33
Enterprise Value/Revenue1.98
Enterprise Value/Gross Profit6.21
Enterprise Value/Ebitda12.84
Forecast
1Y Price Target
$48.33Price Target Upside-10.30% Downside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)2.95
Revenue Forecast (FY)$1.48B
Bulls Say, Bears Say
Bulls Say
Management Guidance And Earnings OutlookAnalyst points to management's raised full-year guidance as evidence of increased confidence in the company's sales and earnings momentum.
Product Demand And International ExpansionAnalyst highlights stronger-than-expected demand for medicated feed additives and favorable livestock sector trends that support expansion into international markets and new product lines.
Product Portfolio IntegrationAnalyst notes that the recently acquired product portfolio is expanding sales and market share through effective execution and cross-selling into existing channels.
Bears Say
Cost Pressures And Margin RiskAnalyst warns that tariff-driven inventory costs combined with planned increases in selling and administrative expenses could cause modest margin deterioration.
Leverage And Leadership TransitionAnalyst flags elevated leverage and an ongoing CEO transition as sources of execution risk and uncertainty around the company's capital structure.
Relative Profitability And GrowthAnalyst maintains an underperform rating citing operating profitability and earnings growth that lag peer companies, indicating weaker competitive positioning.
Phibro Animal Health News
PAHC FAQ
What was Phibro Animal Health’s price range in the past 12 months?
Phibro Animal Health lowest stock price was $16.16 and its highest was $57.62 in the past 12 months.
What is Phibro Animal Health’s market cap?
Phibro Animal Health’s market cap is $2.19B.
When is Phibro Animal Health’s upcoming earnings report date?
Phibro Animal Health’s upcoming earnings report date is May 13, 2026 which is in 44 days.
How were Phibro Animal Health’s earnings last quarter?
Phibro Animal Health released its earnings results on Feb 04, 2026. The company reported $0.87 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.2.
Is Phibro Animal Health overvalued?
According to Wall Street analysts Phibro Animal Health’s price is currently Overvalued.
Does Phibro Animal Health pay dividends?
Phibro Animal Health pays a Quarterly dividend of $0.12 which represents an annual dividend yield of 1.28%. See more information on Phibro Animal Health dividends here
What is Phibro Animal Health’s EPS estimate?
Phibro Animal Health’s EPS estimate is 0.71.
How many shares outstanding does Phibro Animal Health have?
Phibro Animal Health has 20,623,682 shares outstanding.
What happened to Phibro Animal Health’s price movement after its last earnings report?
Phibro Animal Health reported an EPS of $0.87 in its last earnings report, beating expectations of $0.67. Following the earnings report the stock price went up 21.953%.
Which hedge fund is a major shareholder of Phibro Animal Health?
Currently, no hedge funds are holding shares in PAHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Phibro Animal Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$48.33 (-10.30% Downside)
$48.33 (-10.30% Downside)
Blogger Sentiment
Bullish
PAHC Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 63.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 6.2%
Last 30 Days ▲ 6.2%
Last 30 Days ▲ 6.2%
News Sentiment
Very Bullish
Bullish news 94%
Bearish news 6%
Bearish news 6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
151.83%
12-Months-Change
Fundamentals
Return on Equity
30.81%
Trailing 12-Months
Asset Growth
9.34%
Trailing 12-Months
Company Description
Phibro Animal Health
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.
PAHC Company Deck
PAHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum driven primarily by the Animal Health segment, successful MFA integration, robust revenue (+21% Q2) and adjusted EBITDA growth (+41%), and an upward revision to FY26 guidance across sales, EBITDA and adjusted net income. Offsetting items include a one-time/timing-related $10M pullback in legacy MFA sales, a notable decline in Performance Products (-10%), inventory build-up that pressured cash flow, higher SG&A and interest costs, and elevated leverage metrics. Overall the positives (strong top-line & margin expansion, raised guidance, integration execution and product traction) materially outweigh the transitory challenges and modest near-term headwinds.View all PAHC earnings summariesPAHC Stock 12 Month Forecast
Average Price Target
$48.33
▼(-10.30% Downside)
Technical Analysis
Ownership Overview
1.04% Insiders
20.49% Mutual Funds
17.15% Other Institutional Investors
36.51% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---